217 related articles for article (PubMed ID: 33155662)
1. Zoledronic acid impairs oral cancer stem cells by reducing CCL3.
Lee SH; Rigas N; Martin CE; Nguyen A; Kang MK; Park NH; Kim RH; Shin KH
Oncol Rep; 2021 Jan; 45(1):291-298. PubMed ID: 33155662
[TBL] [Abstract][Full Text] [Related]
2. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
3. Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.
Lee SH; Rigas NK; Lee CR; Bang A; Srikanth S; Gwack Y; Kang MK; Kim RH; Park NH; Shin KH
Oncotarget; 2016 Jul; 7(28):43239-43255. PubMed ID: 27259269
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Inoue S; Arai N; Tomihara K; Takashina M; Hattori Y; Noguchi M
Eur J Pharmacol; 2015 Aug; 761():44-54. PubMed ID: 25934567
[TBL] [Abstract][Full Text] [Related]
5. Chronic Alcohol Exposure Promotes Cancer Stemness and Glycolysis in Oral/Oropharyngeal Squamous Cell Carcinoma Cell Lines by Activating NFAT Signaling.
Nguyen A; Kim AH; Kang MK; Park NH; Kim RH; Kim Y; Shin KH
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077186
[TBL] [Abstract][Full Text] [Related]
6. Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression.
Nguyen A; Sung Y; Lee SH; Martin CE; Srikanth S; Chen W; Kang MK; Kim RH; Park NH; Gwack Y; Kim Y; Shin KH
Cells; 2023 Sep; 12(18):. PubMed ID: 37759448
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis.
Rouhrazi H; Turgan N; Oktem G
Biotech Histochem; 2018; 93(2):77-88. PubMed ID: 29300112
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
11. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
Yu CC; Hu FW; Yu CH; Chou MY
Head Neck; 2016 Apr; 38 Suppl 1():E231-8. PubMed ID: 25545959
[TBL] [Abstract][Full Text] [Related]
13. TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells.
Lee SH; Hong HS; Liu ZX; Kim RH; Kang MK; Park NH; Shin KH
Biochem Biophys Res Commun; 2012 Jul; 424(1):58-64. PubMed ID: 22728043
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J
Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
[TBL] [Abstract][Full Text] [Related]
16. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
Yu CC; Chang YC
Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
[TBL] [Abstract][Full Text] [Related]
18. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of oral microbiota in oral cancer initiation, progression and stemness.
Saikia PJ; Pathak L; Mitra S; Das B
Front Immunol; 2023; 14():1198269. PubMed ID: 37954619
[TBL] [Abstract][Full Text] [Related]
20. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y
Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
